How To Spot a 100% Winner
It wasn’t long ago that I highlighted Planet Labs as a stock with the potential to blast off. At the time it was sitting at $1.90 per share.
Fast forward to the present and Planet Labs has soared well above $4 per share and is now posting gains of over 100%.
So what was it that revealed the hallmarks of a stock about to pop? » Read more about: How To Spot a 100% Winner »
Read More
3 Must-See Entertainment Stocks for Your Portfolio
[1] Disney
The Walt Disney Company is known for its ability to create high-quality, imaginative content that appeals to people of all ages. From classic films to modern franchises, Disney has a reputation for producing stories and characters that are beloved by many.
However, the company’s appeal extends beyond its enchanting brand.
» Read more about: 3 Must-See Entertainment Stocks for Your Portfolio »
Read More
1 Inflation-Beating Stock That Passes Buffett’s Test
In times of uncertainty, it can be helpful to tap into the wisdom of Warren Buffett, who was active in the market during the last time inflation was this high in the early 1980s. In his 1982 letter to shareholders, Buffett pointed out that businesses that excel in inflationary environments have two key qualities.
First,
» Read more about: 1 Inflation-Beating Stock That Passes Buffett’s Test »
Read More
Sayonara Carvana
Carvana’s revenue rose 101% in 2019, grew 42% in 2020, even as the COVID-19 pandemic disrupted traditional dealerships, and soared 129% in 2021.
However, in the first nine months of 2022, Carvana’s revenue only grew 19% year-over-year to $10.8 billion, as the market demand for used vehicles cooled off. Despite this slowdown in growth,
» Read more about: Sayonara Carvana »
Read More
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
Has Medical Properties Trust Bottomed Out? The Case for a Comeback
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on hospitals and other medical facilities. The company has been through an extremely trying couple of years, resulting in both dividend cuts and deteriorating share prices.
Now, however, things seem to finally be improving at Medical Properties Trust. Is MPW a buy as the business turns itself around,
» Read more about: Has Medical Properties Trust Bottomed Out? The Case for a Comeback »
Read MoreThe Spotlight
Why This Beverage Giant Can’t Be Toppled
A famous book on business was titled Barbarians at the Gate, documenting the leveraged buyout of RJR Nabisco. If nothing else, it highlights how just the sniff of an opportunity to make money can drive money seekers to make wild decisions.
Some giant businesses have been on the receiving end of similar threats to their solvency as invaders attempt to take their share.
» Read more about: Why This Beverage Giant Can’t Be Toppled »
Read MoreThe Daily
Wall Street Loves Qualcomm, NVIDIA, and Super Micro Stocks Today
Quick Read
-
Nvidia (NVDA) received multiple analyst upgrades with Loop Capital raising its price target to $350,
» Read more about: Wall Street Loves Qualcomm, NVIDIA, and Super Micro Stocks Today »